Informações:
Falhas:
ID
31215
Descrição
AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00961415
Link
https://clinicaltrials.gov/show/NCT00961415
Palavras-chave
Versões (1)
- 29/07/2018 29/07/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
29 de julho de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00961415
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00961415
- StudyEvent: Eligibility
Similar models
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00961415
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adults >/=18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Non-squamous non-small cell lung cancer Inoperable | Non-squamous non-small cell lung cancer Advanced Locally | Non-squamous non-small cell lung cancer metastatic | Non-squamous non-small cell lung cancer Recurrent
Item
inoperable, locally advanced, metastatic or recurrent non-squamous nsclc
boolean
C4324656 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C4324656 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C4324656 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C4324656 (UMLS CUI [4,1])
C2945760 (UMLS CUI [4,2])
C0205187 (UMLS CUI [1,2])
C4324656 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C4324656 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C4324656 (UMLS CUI [4,1])
C2945760 (UMLS CUI [4,2])
Measurable lesion Quantity
Item
at least 1 measurable lesion meeting recist criteria
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
adequate hematological, liver and renal function
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Prior Chemotherapy | Antineoplastic Agents Systemic
Item
prior chemotherapy or treatment with another systemic anti-cancer agent
boolean
C1514457 (UMLS CUI [1])
C0003392 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0003392 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Cancer Other | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Prostate carcinoma Localized | DCIS
Item
malignancies other than nsclc within 5 years prior to randomization, except for adequately treated cracinoma in situ of the cervix, basal or squameous cell skin cancer, localized prostate cancer or dcis
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C0600139 (UMLS CUI [5,1])
C0392752 (UMLS CUI [5,2])
C0007124 (UMLS CUI [6])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C0600139 (UMLS CUI [5,1])
C0392752 (UMLS CUI [5,2])
C0007124 (UMLS CUI [6])
Tumor Invasion Blood Vessels Major
Item
evidence of tumour invading major blood vessels
boolean
C1269955 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Item
current or recent use of aspirin (>325mg/day) or full-dose anticoagulants or thrombolytic agents for therapeutic purposes
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
Hemoptysis Grade
Item
history of haemoptysis >/=grade 2
boolean
C0019079 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0441800 (UMLS CUI [1,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])